The company says the model is available in ChatGPT, Codex, and the API; published pricing takes effect October 5, 2026. OpenAI also introduced a free Codex Life Sciences plugin connecting models to more than 50 scientific tools and data sources. In company-reported evaluations, GPT-Rosalind outperformed GPT-5.4 on six of eleven LABBench2 tasks. These are vendor-reported benchmark results, not evidence of improved clinical outcomes.
Shared context between GPT-Rosalind 's scientific reasoning and program-level decisions.
In one minute
OpenAI says GPT-Rosalind, its specialized life-sciences model, is now globally available to eligible organizations through its trusted-access program, moving out of research preview.
What changed: GPT-Rosalind has exited research preview and is now globally available to eligible organizations through a trusted-access program, with pricing taking effect October 5, 2026.